PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F14LN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $52,173
Award facts
- Contract value 100% obligated
- $52,173.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $52,173 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 20, 2026, with completion scheduled for January 21, 2026. This non-set-aside contract is a child order issued under AmerSourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.999 billion through December 2031. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider to federal military and veteran healthcare systems, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
This delivery order represents a routine medical supply procurement under the broader pharmaceutical prime vendor contract vehicle established to support global military healthcare programs. AmerSourceBergen's role as a major pharmaceutical distributor positions it to fulfill diverse medical commodity requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The firm fixed-price structure and short performance timeline reflect the operational necessity of maintaining consistent pharmaceutical supply chains for military treatment facilities and veteran healthcare programs. The award to AmerSourceBergen follows the DLA's strategy of leveraging large-scale indefinite delivery contracts to ensure efficient and flexible distribution of essential medications and medical supplies to government healthcare organizations.
Quick answers
Who was awarded contract SPE2D826F14LN?
SPE2D826F14LN was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 20, 2026.
How much is contract SPE2D826F14LN worth?
The government has obligated $52,173 on SPE2D826F14LN.
Is contract SPE2D826F14LN an order under another contract?
Yes. SPE2D826F14LN is a delivery order under SPE2DX22D0029, an indefinite delivery contract.
Was contract SPE2D826F14LN competed?
The extent of competition for SPE2D826F14LN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award